fbpx

molecules of the month

ARD-2585

oral CRBN-based androgen receptor degrader

preclinical eff. at 10 mpk QD (xenograft)

from previously disclosed AR molecule

Journal of Medicinal Chemistry

University of Michigan

Chemical structure of ARD-2585
1 min read

The Michigan bifunctional degrader, ARD-2585, is similar to the Arvinas molecule, ARV-110 that was recently disclosed at AACR 2021. ARV-110 is a first-in-class, potent, and orally active AR degrader in clinical development, but understandably hasn’t had much published on it yet given the competitive environment. The publication of ARD-2585 therefore provides nice insight into the properties of this class of molecules. ARD-2585 interestingly uses a rigid, linear linked piperidine-azetidine linker to connect the AR ligand and CRBN ligand, and is up to 1000x more potent than ARV-110 in AR reduction in vitro, and is active in a xenograft model at 10 mpk QD PO. 


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: